These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Preface for special issue "Advances in treatment and care in metastatic breast cancer". Yamamoto Y; Tamura K Chin Clin Oncol; 2018 Jun; 7(3):22. PubMed ID: 30056725 [No Abstract] [Full Text] [Related]
3. Medicine: Eyes on the target. Eisenstein M Nature; 2015 Nov; 527(7578):S110-2. PubMed ID: 26580159 [No Abstract] [Full Text] [Related]
4. Breast cancer. Woolston C Nature; 2015 Nov; 527(7578):S101. PubMed ID: 26580154 [No Abstract] [Full Text] [Related]
6. Breast intervention and breast cancer treatment options. Peart O Radiol Technol; 2015; 86(5):535M-558M; quiz 559-62. PubMed ID: 25995413 [TBL] [Abstract][Full Text] [Related]
7. New Developments in Breast Cancer and Their Impact on Daily Practice in Pathology. Li X; Oprea-Ilies GM; Krishnamurti U Arch Pathol Lab Med; 2017 Apr; 141(4):490-498. PubMed ID: 28353377 [TBL] [Abstract][Full Text] [Related]
8. Clinical Diagnosis and Management of Breast Cancer. McDonald ES; Clark AS; Tchou J; Zhang P; Freedman GM J Nucl Med; 2016 Feb; 57 Suppl 1():9S-16S. PubMed ID: 26834110 [TBL] [Abstract][Full Text] [Related]
10. Molecular markers for breast cancer diagnosis, prognosis and targeted therapy. Lang JE; Wecsler JS; Press MF; Tripathy D J Surg Oncol; 2015 Jan; 111(1):81-90. PubMed ID: 25091830 [TBL] [Abstract][Full Text] [Related]
11. Advancing Immunotherapy in Metastatic Breast Cancer. Mansour M; Teo ZL; Luen SJ; Loi S Curr Treat Options Oncol; 2017 Jun; 18(6):35. PubMed ID: 28534250 [TBL] [Abstract][Full Text] [Related]
12. Novel targeted agents for the treatment of advanced breast cancer. de la Vega M; Díaz-Cantón E; Alvarez RH Future Med Chem; 2012 May; 4(7):893-914. PubMed ID: 22571614 [TBL] [Abstract][Full Text] [Related]
13. Notch signaling pathway as a therapeutic target in breast cancer. Al-Hussaini H; Subramanyam D; Reedijk M; Sridhar SS Mol Cancer Ther; 2011 Jan; 10(1):9-15. PubMed ID: 20971825 [TBL] [Abstract][Full Text] [Related]
15. Expanded role of cytopathology in breast cancer diagnosis, therapy and research: the impact of fine needle aspiration biopsy and imprint cytology. Masood S Breast J; 2012; 18(1):1-2. PubMed ID: 22226067 [No Abstract] [Full Text] [Related]
16. Consequences of the Convergence of Multiple Alternate Pathways on the Estrogen Receptor in the Treatment of Metastatic Breast Cancer. Glück S Clin Breast Cancer; 2017 Apr; 17(2):79-90. PubMed ID: 27687476 [TBL] [Abstract][Full Text] [Related]
18. The immune system and response to HER2-targeted treatment in breast cancer. Bianchini G; Gianni L Lancet Oncol; 2014 Feb; 15(2):e58-68. PubMed ID: 24480556 [TBL] [Abstract][Full Text] [Related]
19. EDITORIAL: Molecularly targeted treatments for colorectal cancer: advances and limitations. Parodi S Curr Cancer Drug Targets; 2012 May; 12(4):301-2. PubMed ID: 22385508 [No Abstract] [Full Text] [Related]
20. Luminal-B breast cancer and novel therapeutic targets. Tran B; Bedard PL Breast Cancer Res; 2011; 13(6):221. PubMed ID: 22217398 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]